| 1. | Varghese, A. J., Gulyas, S., and Mohindra, J. K. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2- propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo, Cancer Res. 36: 3761-3765, 1976. |
| 2. | Chacon, E., Morrow, C. J., Leon, A. A., Born, J. L., and Smith, B. R. Regioselective formation of a misonidazole-glutathione conjugate as a function of pH during chemical reduction., Biochem. Pharmacol. 37: 361-363, 1988. |
| 3. | Raleigh, J. A., Franko, A. J., Koch, C. J., and Born, J. L. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label, Br. J. Cancer. 51: 229-235, 1985. |
| 4. | Raleigh, J. A. and Koch, C. J. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules, Biochem Pharmacol. 40: 2457-2464, 1990. |
| 5. | Varghese, A. J. Glutathione conjugates of misonidazole, Biochem Biophys Res Commun. 112: 1013-1020, 1983. |
| 6. | Arteel, G. E., Thurman, R. G., Yates, J. M., and Raleigh, J. A. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver, Br J Cancer. 72: 889-895, 1995. |
| 7. | Arteel, G. E., Thurman, R. G., and Raleigh, J. A. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state., Eur. J. Biochem. 253: 743-750, 1998. |
| 8. | Chapman, J. D., Franko, A. J., and Sharplin, J. A marker for hypoxic cells in tumours with potential clinical applicability, Br. J. Cancer. 43: 546-550, 1981. |
| 9. | Urtasun, R. C., Koch, C. J., Franko, A. J., Raleigh, J. A., and Chapman, J. D. A novel technique for measuring human tissue pO2 at the cellular level, Br. J. Cancer. 54: 453-457, 1986. |
| 10. | Raleigh, J. A., Dewhirst, M. W., and Thrall, D. E. Measuring tumor hypoxia., Sem. Radiat. Oncol. 6: 37-45, 1996. |
| 11. | Jin, G. Y., Li, S. J., Moulder, J. E., and Raleigh, J. A. Dynamic measurements of hexafluoromisonidazole (CCI-103F) retention in mouse tumours by 1H/19F magnetic rsonance spectroscopy, Int. J. Radiat. Biol. 58: 1025-1034, 1990. |
| 12. | Raleigh, J. A., Franko, A. J., Treiber, E. O., Lunt, J. A., and Allen, P. S. Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in BALB/C mice: Detection by F-19 nuclear magnetic resonance at 2.35T, Int. J. Radiat. Oncol. Biol. Phys. 12: 1243-1245, 1986. |
| 13. | Raleigh, J., Franko, A., Kelly, D., Trimble, L., and Allen, P. Development of an in vivo 19F magnetic resonance method for measuring oxygen deficiency in tumors., Magn. Res. Med. 22: 451-466, 1991. |
| 14. | Raleigh, J. A., Miller, G. G., Franko, A. J., Koch, C. J., Fuciarelli, A. F., and Kelly, D. A. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours, Br J Cancer. 56: 395-400, 1987. |
| 15. | Raleigh, J. A., Miller, G. G., Franko, A. J., and Chapman, J. D. Immunochemical detection of hypoxia in normal and tumor tissue. USA patent 5,086,068, February,1992. |
| 16. | Azuma, C., Raleigh, J. A., and Thrall, D. E. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime., Radiat. Res. 148: 35-42, 1997. |
| 17. | Cline, J. M., Thrall, D. E., Page, R. L., Franko, A. J., and Raleigh, J. A. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours., Br. J. Cancer. 62: 925-931, 1990. |
| 18. | Cline, J. M., Thrall, D. E., Rosner, G. L., and Raleigh, J. A. Distribution of the hypoxia marker CCI-103F in canine tumors, Int J Radiat Oncol Biol Phys. 28: 921-933, 1994. |
| 19. | Cline, J., Rosner, G., Raleigh, J., and Thrall, D. Quantification of CCI-103F labeling heterogeneity in canine solid tumors, Int. J. Radiat. Oncol. Biol. Phys. 37: 655-662, 1997. |
| 20. | Thrall, D. E., McEntee, M. C., Cline, J. M., and Raleigh, J. A. ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation., Int. J. Radiat. Oncol. Biol. Phys. 28: 649-659, 1994. |
| 21. | Thrall, D. E., Rosner, G. L., Azuma, C., McEntee, M. C., and Raleigh, J. A. Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning, Radiother Oncol. 44: 171-6, 1997. |
| 22. | Evans, S. M., Hahn, S., Pook, D. R., Jenkins, W. T., Chalian, A. A., Zhang, P., Stevens, C., Weber, R., Weinstein, G., Benjamin, I., Mirza, N., Morgan, M., Rubin, S., McKenna, W. G., Lord, E. M., and Koch, C. J. Detection of hypoxia in human squamous cell carcinoma by EF5 binding, Cancer Res. 60: 2018-2024, 2000. |
| 23. | Kennedy, A. S., Raleigh, J. A., Perez, G. M., Calkins, D. P., Thrall, D. E., Novotny, D. B., and Varia, M. A. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays, Int J Radiat Oncol Biol Phys. 37: 897-905, 1997. |
| 24. | Raleigh, J. A., Calkins-Adams, D. P., Rinker, L. H., Ballenger, C. A., Weissler, M. C., Fowler, W. C., Jr., Novotny, D. B., and Varia, M. A. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker, Cancer Res. 58: 3765-3768, 1998. |
| 25. | Raleigh, J., Chou, S.-C., Calkins-Adams, D., Ballenger, C., Rinker, L., Novotny, D., and Varia, M. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas, Cl. Cancer Res. 6: 855-862, 2000. |
| 26. | Varia, M. A., Calkins-Adams, D. P., Rinker, L. H., Kennedy, A. S., Novotny, D. B., Fowler, W. C., Jr., and Raleigh, J. A. Pimonidazole : a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma., Gynecol. Oncol. 71: 270-277, 1998. |
| 27. | Wijffels, K., Kaanders, J., Rijken, P., Bussink, J., Van den Hoogen, F., Marres, H., de Wilde, P., Raleigh, J., and Van der Kogel, A. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas., Br. J. Cancer. 83: 674-683, 2000. |
| 28. | Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., and Keshet, E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis, Nature. 394: 485-90, 1998. |
| 29. | Hodgkiss, R. J. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia, Anticancer Drug Des. 13: 687-702, 1998. |
| 30. | Koch, C. J., Chasan, J. E., Jenkins, W. T., Chan, C. Y., Laughlin, K. M., and Evans, S. M. Co-localization of hypoxia and apoptosis in irradiated and untreated HCT116 human colon carcinoma xenografts, Adv Exp Med Biol. 454: 611-618, 1998. |
| 31. | Raleigh, J. A., Zeman, E. M., Calkins, D. P., McEntee, M. C., and Thrall, D. E. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors, Acta Oncol. 34: 345-349, 1995. |
| 32. | Raleigh, J. A., Chou, S.-C., Tables, L., Suchindran, S., Varia, M. A., and Horsman, M. R. Relationship of hypoxia to metallothionein expression in murine tumors., Int. J. Radiat. Oncol. Biol. Phys. 42: 727-730, 1998. |
| 33. | Waleh, N. S., Brody, M. D., Knapp, M. A., Mendonca, H. L., Lord, E. M., Koch, C. J., Laderoute, K. R., and Sutherland, R. M. Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker., Cancer Res. 55: 6222-6226, 1995. |
| 34. | Leith, J. T. and Michelson, S. Secretion rates and levels of vascular endothelial growth factor in clone A or HCT-8 human colon tumour cells as a function of oxygen concentration, Cell Prolif. 28: 415-430, 1995. |
| 35. | Murphy, B. J., Andrews, G. K., Bittel, D., Discher, D. J., McCue, J., Green, C. J., Yanovsky, M., Giaccia, A., Sutherland, R. M., Laderoute, K. R., and Webster, K. A. Activation of metallothionein gene expression by hypoxia involves metal response elements and MTF-1., Cancer Res. 59: 1315-1322, 1999. |
| 36. | Durand, R. E. and Raleigh, J. A. Identification of nonproliferating but viable hypoxic cells in vivo., Cancer Res. 58: 3547-3550, 1998. |
| 37. | Webster, L., Hodgkiss, R. J., and Wilson, G. D. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours, Cytometry. 21: 344-351, 1995. |
| 38. | Smithen, C., Clarke, E., Dale, J., Jacobs, R., Wardman, P., Watts, M., and Woodcock, M. Novel (nitro-1-imidazoyl)-alkanolamines as potential radiosensitizers with improved therapeutic properties. In: L. Brady (ed.) Radiation Sensitizers. Their Use in the Clinical Management of Cancer., pp. 22-32. New York: Masson, 1980. |
| 39. | Saunders, M. I., Anderson, P. J., Bennett, M. H., Dische, S., Minchinton, A. I., and Stratford, M. R. L. The clinical testing of Ro 03-8799 -- pharmacokinetics, toxicology, tissue and tumor concentrations., Int. J. Radiat. Oncol. Biol. Phys. 10: 1759-1763, 1984. |
| 40. | Arteel, G. E., Iimuro, Y., Yin, M., Raleigh, J. A., and Thurman, R. G. Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo, Hepatology. 25: 920-926, 1997. |
| 41. | Bussink, J., Kaanders, J. H., Rijken, P. F., Raleigh, J. A., and Van Der Kogel, A. J. Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line., Radiat. Res. 153: 398-404, 2000. |
| 42. | Rijken, P., Bernsen, H., Peters, J., Hodgkiss, R., Raleigh, J., and van der Kogel, A. Spatial relationship between hypoxia and the (perfused) vascular network in human glioma xenografts: a quantitative multi-parameter analysis., Int.J. Radiat. Oncol. Biol. Phys. 48: 571-582, 2000. |
| 43. | Bernsen, H. J., Rijken, P. F., Peters, H., Raleigh, J. A., Jeuken, J. W., Wesseling, P., and van der Kogel, A. J. Hypoxia in a human intracerebral glioma model, J Neurosurg. 93: 449-454, 2000. |
| 44. | Chou, S. C., Flood, P. M., and Raleigh, J. A. Marking hypoxic cells for complement and cytotoxic T lymphocyte- mediated lysis: using pimonidazole, Br J Cancer Suppl. 27: S213-s216, 1996. |
| 45. | Ljungkvist,ASE, Bussink, J, Raleigh, JA, Denekemp, J and van der Kogel, AJ. Changes in tumor hypoxia measured with a double hypoxic marker technique, Int. J. Radiat. Oncol. Biol. Phys. 48: 1529-1538, 2000. |
| 46. | Wykoff, CC, Beasley, NJ, Watson, PH, Turner, KJ, Pastorek, J, Sibtain, A, Wilson, GD, Turley, H, Talks, KL, Maxwell, PH, Pugh, CW, Ratcliffe, PJ and Harris, AL. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60: 7075-7083, 2000. |
| 47. | Rofstad, EK and Maseide, K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int. J. Radiat. Biol. 75: 1377-93, 1999. |
| 48. | Newman, HFV, Bleehen, NM, Ward, R and Workman, P. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: A new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole). Int. J. Radiat. Oncol. Biol. Phys. 15: 677-684; 1988. |
| 49. | Roberts, JT, Bleehen, NM, Walton, MI, and Workman, P. A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics. Br. J. Radiology 59: 107-116; 1986. |
| 50. | Olive, PL, Aquino-Parsons, C, MacPhail, SH, Liao, S-Y, Raleigh, JA, Lerman, MI, and Stanbridge, EJ. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res. 61:8924-8929, 2001. |
| 51. | Olive, PL, Banath, JP, and Aquino-Parsons, C. Measuring hypoxia in solid tumors. Is there a gold standard? Acta Oncologica 40: 917-923, 2001. |
| 52. | Yin M., Zhong Z., Connor H.D, Bunzendahl H., Finn W.F., Rusyn I., Li X., Raleigh J.A., Mason R.P., Thurman R.G. Protective effect of glycine on renal injury induced by ischemia-reperfusion in vivo. Am. J. Physiol. Renal Physiol. 282: F417-423, 2002. |
| 53. | Ghafar M.A, Anastasiadis A.G., Olsson LE., Chichester P., Kaplan S.A, Buttyan R., Levin R.M. Hypoxia and an angiogenic response in the partially obstructed rat bladder. Lab. Invest. 82: 903-909, 2002. |
| 54 . | Dewhirst, M.W., Braun, R.D. and Lanzen, J.L. Temporal changes in pO2 of R3230AC tumors in Fischer-344 rats, Int J Radiat Oncol Biol Phys 42: 723-726, 1998. |
| 55. | Hochachka, P.W. Patterns of O2-dependence of metabolism, Adv Exp Med Biol 222: 143-151, 1988. |
| 56. | Wouters, B.G. and Brown, J.M. Cells at intermediate oxygen levels can be more important than the hypoxic fraction; in determining tumor response to fractionated radiotherapy, Radiat Res 147: 541-550, 1997. |
| 57. | Arteel et al., Acute alcohol produces hypoxia directly in rat liver tissue in vivo: role of Kupffer cells, Am J Physiol 271: G494-500, 1996. |
| 58. | McKim et al., Chronic intragastric alcohol exposure causes hypoxia and oxidative stress in the rat pancreas, Arch Biochem Biophys 417: 34-43, 2003. |
| 59. | Zhong et al., Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine, Am J Physiol 275: F595-604, 1998). |
| 60. | Ross, W.J.C., Increased sensitivity of Walker tumours towards aromatic nitrogen mustards carrying basic side chains following glucose pretreatment, Biochem Pharmacol 8: 235-240, 1961. |
| 61. | Wardman, P. Molecular structure and biological activity of hypoxic cell radiosensitizers and hypoxic specific cytotoxins, Advanced Topics on Radiosensitizers of Hypoxic Cells (Eds. A. Breccia, C. Rimondi and G.E. Adams), Plenum Press, New York, pp. 49-75, 1982. |
| 62. | Dennis, M.F., Stratford, M.R., Wardman, P. and Watts, M.E. Cellular uptake of misonidazole and analogues with acidic or basic functions, Int J Radiat Biol 47: 629-643, 1985. |
| 63. | Kleiter, M.M., Thrall, D.E., Malarkey, D.E., Ji, X., Lee, D.Y., Chou, S.-C., and Raleigh, J.A. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int J Radiat Oncol Biol Phys, 64: 592-602, 2006. |
| 64. | Helmlinger, G., Yuan, F., Dellian, M. and Jain, R. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation, Nature, Medicine 3: 177-182, 1997. |
| 65. | Gross, M.W., Karbach, U., Groebe, K., Franko, A.J. and Mueller-Klieser, W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids, Int. J. Cancer 61: 567-573, 1995. |
| 66. | Chou, S. C., Azuma, Y., Varia, M. A., and Raleigh, J. A. Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. Br. J. Cancer, 90: 728-735, 2004. |